Gracell Biotechnologies

Gracell Biotechnologies

featured image of AstraZeneca's $12bn Chinese Biotech Power Move
Companies

AstraZeneca’s $12bn Chinese Biotech Power Move

BIOT

🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.

Previous 12

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact